Objective To evaluate the clinical efficacy of kebite combivent and aerosol budesonide suspension on infants bronchiolitis. Methods A total of 72 patients with bronchial pneumonia were recruited from January 2006 to December 2008. The age range were from 27 days to 2 years (8 months average) The therapy group (39 cases randomly) were treated with Kebite Combivent and aerosol budesonide suspension (driving the airgun with 6L/ml oxygen), while the control group (33 cages) with traditional treatment ( β2-receptor agonist orally or aminophylline intravenously). Both were treated with anti-infection treatments in the same time. Therapeutic effects were evaluated 7 days later, Results The healing rate of therapy group was 97.44% and that of control group was 66.67%. Both of them were significant difference (P< 0.05). Conclusion Association with Kebite Combivent and aerosol budesonide suspension is an effective, convenient treatment for infants' bronehiolitis with little side effects.%目的 探讨可必特联合普米克令舒雾化吸入佐治毛细支气管炎的疗效.方法 选择我院2006年1月-2008年10月支气管肺炎住院患儿72例,随机分为治疗组39例,对照组33例;两组患儿均采用吸氧、抗病毒、抗炎、止咳、祛痰、平喘等治疗.治疗组加用可必特及普米克令舒联合雾化吸入,对治疗后症状、体征消失时间以及治愈率进行比较.结果 咳嗽消失、缓解喘憋及缩短肺部啰音时间均明显优于对照组,两组比较有显著性差异(P＜0.05).治疗组治愈率为97.44%,对照组治愈率为66.67%.结论 可必特及普米克令舒雾化吸入佐治毛细支气管炎有显著疗效,适合婴幼儿使用.
展开▼
